Virtus LifeSci Biotech Pr... (BBP)
NYSEArca: BBP
· Real-Time Price · USD
103.48
+0.75 (0.73%)
At close: Aug 18, 2026, 3:50 PM
Virtus LifeSci Biotech Products ETF (BBP) ETF Price, Holdings & Analysis
0.73% (1D)
| Bid | 0 |
| Market Cap | n/a |
| AUM | 98.54M |
| NAV | 102.67 |
| Beta | 0.76 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | n/a |
| Inception Date | Dec 16, 2014 |
| Ask | 0 |
| Volume | 6,295 |
| Avg. Volume (20D) | 8,692 |
| Open | 101.99 |
| Previous Close | 102.73 |
| Day's Range | 102.92 - 103.48 |
| 52-Week Range | 66.55 - 105.21 |
| Holdings | n/a |
| Expense Ratio | 0.34% |
About BBP
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
Asset Class Equity
Ticker Symbol BBP
Inception Date Dec 16, 2014
Provider Virtus
Website Fund Home Page
Exchange NYSEArca
Top 10 Holdings 19.61% of assets
| Name | Symbol | Weight |
|---|---|---|
| Crinetics Pharmaceut... | CRNX | 3.34% |
| Kiniksa Pharmaceutic... | KNSA | 1.97% |
| Verastem Inc | VSTM | 1.95% |
| Precigen Inc | PGEN | 1.94% |
| Omeros Corp | OMER | 1.87% |
| Nuvation Bio Inc Ord... | NUVB | 1.77% |
| Regeneron Pharmaceut... | REGN | 1.72% |
| Protagonist Therapeu... | PTGX | 1.71% |
| Acadia Pharmaceutica... | ACAD | 1.69% |
| Bridgebio Pharma Inc | BBIO | 1.65% |
Dividends Dividend Yield 0.07%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 20, 2017 | $0.0720 | n/a |
| Dec 21, 2015 | $0.3970 | n/a |
